Commission Regulation (EC) No 109/2007 of 5 February 2007 concerning the authorisation of monensin sodium (Coxidin) as a feed additive (Text with EEA relevance )

6.2.2007 EN Official Journal of the European Union L 31/6
COMMISSION REGULATION (EC) No 109/2007
of 5 February 2007
concerning the authorisation of monensin sodium (Coxidin) as a feed additive
(Text with EEA relevance)
THE COMMISSION OF THE EUROPEAN COMMUNITIES
,
Having regard to the Treaty establishing the European Community,
Having regard to Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition (1), and in particular Article 9(2) thereof,
Whereas:
(1) Regulation (EC) No 1831/2003 provides for the authorisation of additives for use in animal nutrition and for the grounds and procedures for granting such authorisation.
(2) In accordance with Article 7 of Regulation (EC) No 1831/2003, an application was submitted for the authorisation of the preparation set out in the Annex to this Regulation. That application was accompanied by the particulars and documents required under Article 7(3) of that Regulation.
(3) The application concerns authorisation of the substance monensin sodium (Coxidin) as a feed additive for chickens for fattening and turkeys, to be classified in the additive category ‘occidiostats and histomonostats’.
(4) The European Food Safety Authority (the Authority) concluded in its opinion of 20 October 2005 that monensin sodium (Coxidin) does not have an adverse effect on animal health, human health or the environment (2). The Authority further concluded that monensin sodium (Coxidin) does not present any other risk which would, in accordance with Article 5(2) of Regulation (EC) No 1831/2003, exclude authorisation. According to that opinion, the use of that product may be effectively used to prevent coccidiosis. This opinion also verified the report on the method of analysis of that feed additive in feed submitted by the Community Reference Laboratory set up by Regulation (EC) No 1831/2003. The Authority concluded that it was necessary to establish maximum residue limits (MRLs). However, it was unable to propose MRLs since the applicant had not provided the data required. After receiving those data the Authority adopted an opinion proposing provisional MRLs on 21 November 2006 (3). It may be necessary to review the MRLs set out in the Annex to this Regulation in the light of the results of a future evaluation of the active substance concerned by the European Agency for the Evaluation of Medicinal Products.
(5) The assessment of that preparation shows that the conditions for authorisation, provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied. Accordingly, the use of that preparation should be authorised, as specified in the Annex to this Regulation.
(6) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,